Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

全面介绍

Gespeichert in:
书目详细资料
Autoren: Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
格式: 文件
语言:英语
出版: Philipps-Universität Marburg 2023
主题:
在线阅读:PDF-Volltext
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

PDF-Volltext

持有资料详情
索引号: urn:nbn:de:hebis:04-es2023-00054
Publikationsdatum: 2023-03-06
Quelle: Erstveröffentlichung: Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.; et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533. https://doi.org/10.3390/vaccines10040533
Downloads: 32 (2024), 32 (2023)
Lizenz: https://creativecommons.org/licenses/by/4.0
访问URL: https://archiv.ub.uni-marburg.de/es/2023/0005
https://doi.org/10.3390/vaccines10040533